ClinicalTrials.Veeva

Menu
D

DaVita Clinical Research | Stone Oak, San Antonio, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Clazakizumab
KBP-5074
BI 685509

Parent organization

This site is a part of DaVita Clinical Research

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

1 of 4 total trials

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

This is a 2-part (phase 2b/3) prospective, interventional, multicenter, randomized, double-blind, placebo-controlled study. Part 1 (phase 2b) is a do...

Enrolling
Atherosclerotic Cardiovascular Disease
Atherosclerotic Cardiovascular Disease in Patients With ESKD
Drug: Placebo
Drug: CSL300

Trial sponsors

Boehringer Ingelheim logo
CSL Behring logo
K

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems